Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
New trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.
Source: medscape.com
Stay updated with breaking news from Triple Inhaler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.